Recombinant Human CCL7/MCP-3, CF

Name Recombinant Human CCL7/MCP-3, CF
Supplier R&D Systems
Catalog 282-P3-010/CF
Category Protein
Nature Recombinant
Source E. coli-derived, Gln34-Leu109
Purity >97%, by SDS-PAGE under reducing conditions and visualized by silver stain.
SwissProt/Accession Q7Z7Q8
Gene CCL7
Supplier Page Shop

Product References

Widespread potential for growth-factor-driven resistance to anticancer kinase - Widespread potential for growth-factor-driven resistance to anticancer kinase

Wilson TR, Fridlyand J, Yan Y, Penuel E, Burton L, Chan E, Peng J, Lin E, Wang Y, Sosman J, Ribas A, Li J, Moffat J, Sutherlin DP, Koeppen H, Merchant M, Neve R, Settleman J. Nature. 2012 Jul 26;487(7408):505-9.

CCL19 is a specific ligand of the constitutively recycling atypical human - CCL19 is a specific ligand of the constitutively recycling atypical human

Leick M, Catusse J, Follo M, Nibbs RJ, Hartmann TN, Veelken H, Burger M. Immunology. 2010 Apr;129(4):536-46.

Tumor-stromal crosstalk in invasion of oral squamous cell carcinoma: a pivotal - Tumor-stromal crosstalk in invasion of oral squamous cell carcinoma: a pivotal

Jung DW, Che ZM, Kim J, Kim K, Kim KY, Williams D, Kim J. Int J Cancer. 2010 Jul 15;127(2):332-44.

Normalizing the bone marrow microenvironment with p38 inhibitor reduces multiple - Normalizing the bone marrow microenvironment with p38 inhibitor reduces multiple

Nguyen AN, Stebbins EG, Henson M, O'Young G, Choi SJ, Quon D, Damm D, Reddy M, Ma JY, Haghnazari E, Kapoun AM, Medicherla S, Protter A, Schreiner GF, Kurihara N, Anderson J, Roodman GD, Navas TA, Higgins LS. Exp Cell Res. 2006 Jun 10;312(10):1909-23. Epub 2006 Apr 4.

CC chemokines and transmigration of eosinophils in the presence of vascular cell - CC chemokines and transmigration of eosinophils in the presence of vascular cell

Yamamoto H, Nagata M, Sakamoto Y. Ann Allergy Asthma Immunol. 2005 Feb;94(2):292-300.

Plasmacytoid dendritic cell recruitment by immobilized CXCR3 ligands. - Plasmacytoid dendritic cell recruitment by immobilized CXCR3 ligands.

Kohrgruber N, Groger M, Meraner P, Kriehuber E, Petzelbauer P, Brandt S, Stingl G, Rot A, Maurer D. J Immunol. 2004 Dec 1;173(11):6592-602.

Identification of full, partial and inverse CC chemokine receptor 3 agonists - Identification of full, partial and inverse CC chemokine receptor 3 agonists

Wan Y, Jakway JP, Qiu H, Shah H, Garlisi CG, Tian F, Ting P, Hesk D, Egan RW, Billah MM, Umland SP. Eur J Pharmacol. 2002 Dec 5;456(1-3):1-10.